Multicenter phase II study of apatinib single or combination therapy in HER2-negative breast cancer involving chest wall metastasis

OBJECTIVE: Breast cancer (BC) with chest wall metastasis (CWM) usually shows rich neovascularization. This trial explored the clinical effect of apatinib on human epidermal growth factor receptor 2 (HER2)-negative advanced BC involving CWM. METHODS: This trial involved four centers in China and was...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Chin J Cancer Res
Hauptverfasser: Li, Huiping, Geng, Cuizhi, Zhao, Hongmei, Jiang, Hanfang, Song, Guohong, Zhang, Jiayang, Liu, Yaxin, Gui, Xinyu, Wang, Jing, Li, Kun, Tong, Zhongsheng, Zhao, Fangyuan, Yang, Junlan, Chen, Guoliang, Liu, Qianyu, Liang, Xu
Format: Artigo
Sprache:Inglês
Veröffentlicht: AME Publishing Company 2021
Schlagworte:
Original Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8181870/
https://ncbi.nlm.nih.gov/pubmed/34158743
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21147/j.issn.1000-9604.2021.02.11
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge